Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...

Insulet (($PODD)) announced an update on their ongoing clinical study. Insulet Corporation is currently conducting a study titled ‘Feasibility of ...

A novel investigational endoscopic procedure targeting the duodenum appears beneficial in improving glycemic parameters in people with type 2 diabetes (T2D). In a new dose-finding study, the ...

Having optimal cardiovascular health may offset the risk of developing mild cognitive impairment and dementia for people with type 2 diabetes (T2D), even among those with a high genetic risk for ...

New research highlights strength training as a powerful tool for managing type 2 diabetes. Lifting weights boosts insulin ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes. Monitoring blood glucose levels is ...

Maya Ramirez, 31, has been attending diabetes camp all her life. In 2023, she attended a diabetes camp for adults for the first time. I was born with a condition called congenital hyperinsulinism, ...

An international study, Colive Voice, presented at the European Association for the Study of Diabetes (EASD) 2024 conference, shows that patients with type 2 diabetes (T2D) have different voice ...

Prediabetes is a condition that develops before the onset of type 2 diabetes. Here's how to know if you're at risk and how to treat it.

A year after Novo Nordisk surrendered its pursuit of an approval in the U.S. for IcoSema as a treatment for Type 2 diabetes, the Danish company has scored a recommendation for the combination drug in ...